Literature DB >> 17638102

Concerning the anti-arthritic action of cetyl myristoleate in rats: an interim report.

M W Whitehouse1, R P McGeary.   

Abstract

The proposed arthro-preventive action of cetyl myristoleate, an OTC product sold as a nutritional supplement, could not be confirmed, using an almost identical bioassay (adjuvant-induced polyarthritis in rats) as that described in the original report (Diehl and May, 1994) with the same, and 3 other, dosing schedules.

Entities:  

Year:  1999        PMID： 17638102     DOI： 10.1007/s10787-999-0014-z

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN： 0925-4692            Impact factor:   5.093


  3 in total

1.  Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production.

Authors:  D R Haynes; S J Gadd; M W Whitehouse; G Mayrhofer; B Vernon-Roberts
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

2.  Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats.

Authors:  H W Diehl; E L May
Journal:  J Pharm Sci       Date:  1994-03       Impact factor: 3.534

3.  Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel.

Authors:  M W Whitehouse; T A Macrides; N Kalafatis; W H Betts; D R Haynes; J Broadbent
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093
  3 in total
  1 in total

1.  Non-NSAID over-the-counter (OTC) remedies for arthritis: good, bad or indifferent?

Authors:  M W Whitehouse; D E Butters
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 5.093
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.